Substitution for protease inhibitors in HIV therapy.
Hirschel
Bernard
B
D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D015658:HIV Infections / Q000188:drug therapy* / Q000209:etiology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019829:Nevirapine / Q000009:adverse effects / Q000627:therapeutic use; D010078:Oxazines / Q000009:adverse effects / Q000627:therapeutic use*; D010352:Patient Dropouts; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D015819:Substance Abuse, Intravenous / Q000150:complications
D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D017320:HIV Protease Inhibitors; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine; C098320:efavirenz